Particle.news

Download on the App Store

UnitedHealth Faces DOJ Criminal Probe as Leadership and Stock Turmoil Deepen

The nation’s largest health insurer is under investigation for potential Medicare fraud while grappling with a 50% stock drop and a sudden CEO change.

The corporate logo of the UnitedHealth Group appears on the side of one of their office buildings in Santa Ana, California, U.S., April 13, 2020. REUTERS/Mike Blake/File Photo
Patients and doctors denounce UnitedHealth in a protest on the steps of Wall Street as the company's record profits were announced on January 16, 2025, in New York City.
Image
Image

Overview

  • The Department of Justice is actively investigating UnitedHealth Group for potential Medicare Advantage fraud, with the probe reportedly ongoing since mid-2023.
  • UnitedHealth has stated it has not been formally notified of the investigation and defends the integrity of its Medicare Advantage program.
  • The company’s stock price has plummeted nearly 50% in the past month, exacerbating financial and operational challenges.
  • Andrew Witty has resigned as CEO, with former CEO and current chairperson Stephen Hemsley stepping into the role during this period of upheaval.
  • This criminal probe adds to ongoing civil fraud and antitrust investigations, heightening regulatory scrutiny on the health insurance giant.